ADHC Overview The Company will be at the forefront of the

New Post Public Reply Private Reply Replies (1) Message Board
John Howard

ADHC Overview

The Company will be at the forefront of the development of a secure mobile software platform that will aid in the collection, analyzing and presentation of data for the healthcare market. We will also be developing for different vertical markets such as Diabetes, Dementia and Alzheimer’s disease. The iPhone is now responsible for 50 percent worldwide and 55 percent US share of AdMob ads served to smartphones. The Android platform is also seeing significant growth in share of mobile ads served. Planned international introductions of Android devices could result in an uptick in its worldwide share in the next few months. The Company will work with the Healthcare Industry and Healthcare providers to acquire content for the fast growing mobile platforms , the early sales estimates for the iPad have been hovering around 3 million to 4 million units in calendar-year 2010, The more realistic number may be more in the area of 6 million. The Company will have an opportunity to execute a strategy of defining Healthcare markets that will require a new secure mobile platform for the collection, analyzing and presentation of data. The Company will be able to evaluate various solutions for the mHealth market and to attack certain medical disciplines that will be using the iPhone, iPad, Android and other mobile platforms. Many large institutions will want to connect using various computer platforms.  The Company will develop methods for software communication among the various mobile devices.

American Diversified Holdings Corp. (ADHC) Stock Research Links

ADHC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Cultural Excellence: Fukuoka Prize 2025 Laureates Revealed

Updated Category News Views 360

Fukuoka City Announces 2025 Fukuoka Prize Winners Fukuoka City has revealed the recipients of the prestigious Fukuoka Prize for 2025, honoring remarkable individuals in the field of Asian studies and the arts. This award is presented to those who excel in preserving and enhancing the rich tapestry of Asian culture. Fukuoka City is dedicated to celebrating these...

Continue Reading
Investors Unite: Join Flywire Corporation Legal Action Today

Updated Category News Views 168

Flywire Corporation Investors Take Action Against Securities Fraud In a moment of reckoning, investors in Flywire Corporation are seizing the opportunity to join a class action lawsuit concerning alleged securities fraud. The filing of this lawsuit has been initiated to hold accountable those responsible for misleading investors during a specified period, marking a...

Continue Reading
Venus Concept Secures $2.7 Million for Growth and Innovation

Updated Category News Views 323

Venus Concept Raises Significant Funds for Future Endeavors Venus Concept Inc. (NASDAQ: VERO), a renowned name in the global medical aesthetic technology arena, recently achieved a noteworthy milestone by closing a registered direct offering that provided around $1.57 million in gross proceeds. The offering consisted of 386,700 shares of common stock, sold at $4.06 each,...

Continue Reading
Revolutionary RAGE: UPENDS Launches Game-Changing Vape System

Updated Category News Views 211

UPENDS Unveils Groundbreaking Open Pod Vape System In a remarkable stride forward for the vaping industry, UPENDS has launched their revolutionary RAGE open pod system, designed to transform how enthusiasts experience vaping. As the European market continues to evolve, this cutting-edge device positions itself as a leader in user-centric innovation and compliance. The...

Continue Reading
Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 101

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading